First long-acting therapy with three-monthly dosing to target root cause of cardiac disease The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending ...
Transthyretin amyloidosis (ATTR) is a protein conformational disorder caused by the build-up of transthyretin, the protein carrying thyroxine and retinol in the bloodstream. While cardiomyopathy is a ...
The prognosis for people with ATTR amyloidosis depends on a range of factors, including the type they have, which organs are impacted, and the kind of treatment they’ve received. In amyloidosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback